IP Verse

Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof - EP2784084B2

PatentPatent Analysis

EP2784084

GENENTECH
Application Number
EP14163686A
Filing Date
Jun 2, 2004
Status
Patent Maintained As Amended
Sep 1, 2023
Grant Date
Oct 4, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2694072B2
EP4108259B1
EP3589661B1

Bibliography

The patent EP2784084B2 was granted to Genentech on Oct 4, 2023 following the initial filing on Jun 2, 2004 under the application number EP14163686A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ELI LILLY GESELLSCHAFTAug 30, 2021INTERVENTION WITHDRAWN
UCB BIOPHARMAApr 23, 2020WITHDRAWN
MERCK PATENTApr 22, 2020WITHDRAWN
ELI LILLY AND LILLY DEUTSCHLANDMar 16, 2020WITHDRAWN
NOVARTISJul 24, 2019WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents